Parfitt, A.M. Bone forming cells in clinical conditions. in The Osteoblast and Osteocyte (ed. Hall, B.K.) 351–426 (Telford, London, 1990).
Kassem, M., Ankersen, L., Eriksen, E.F., Clark, B.F. & Rattan, S.I. Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporos. Int. 7, 514–524 (1997).
Kveiborg, M. et al. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech. Ageing Dev. 106, 261–271 (1999).
Kveiborg, M., Rattan, S.I., Clark, B.F., Eriksen, E.F. & Kassem, M. Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture. J. Cell. Physiol. 186, 298–306 (2001).
Christiansen, M., Kveiborg, M., Kassem, M., Clark, B.F. & Rattan, S.I. CBFA1 and topoisomerase I mRNA levels decline during cellular aging of human trabecular osteoblasts. J. Gerontol. A Biol. Sci. Med. Sci. 55, B194–B200 (2000).
Prescott, J.C. & Blackburn, E.H. Telomerase: Jekyll or Mr Hyde? Curr. Opin. Genet. Dev. 9, 368–373 (1999).
Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785–795 (1997).
Harley, C.B., Futcher, A.B. & Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990).
Kolquist, K.A. et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19, 182–186 (1998).
Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279–282 (1998).
Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
Bianco, P. & Gehron, R.P. Marrow stromal stem cells. J. Clin. Invest. 105, 1663–1668 (2000).
Pittenger, M.F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
Wood, L.D. et al. Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene 20, 278–288 (2001).
Yang, J. et al. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274, 26141–26148 (1999).
Shay, J.W., Pereira-Smith, O.M. & Wright, W.E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33–39 (1991).
Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).
Hahn, W.C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464–468 (1999).
Franco, S. et al. Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT). Exp. Cell Res. 268, 14–25 (2001).
Funk, W.D. et al. Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp. Cell Res. 258, 270–278 (2000).
Yang, J. et al. Telomerized human microvasculature is functional in vivo. Nat. Biotechnol. 19, 219–224 (2001).
Morales, C.P. et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115–118 (1999).
Jiang, X.R. et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21, 111–114 (1999).
Vaziri, H. et al. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol. Cell. Biol. 19, 2373–2379 (1999).
Shay, J.W. & Wright, W.E. The use of telomerized cells for tissue engineering. Nat. Biotechnol. 18, 22–23 (2000).
Rickard, D.J. et al. Isolation and characterization of osteoblast precursor cells from human bone marrow. J. Bone Miner. Res. 11, 312–324 (1996).
Kassem, M., Mosekilde, L. & Eriksen, E.F. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. J. Bone Miner. Res. 8, 1453–1458 (1993).
Chuah, M.K., Vandendriessche, T. & Morgan, R.A. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. Hum. Gene Ther. 6, 1363–1377 (1995).
Serakinci, N., Pedersen, B. & Koch, J. Expansion of repetitive DNA into cytogenetically visible elements. Cytogenet. Cell Genet. 92, 182–185 (2001).
Mackay, A.M. et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4, 415–428 (1998).
Stenderup, K., Justesen, J., Eriksen, E.F., Rattan, S.I. & Kassem, M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J. Bone Miner. Res. 16, 1120–1129 (2001).
Kuznetsov, S.A. et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335–1347 (1997).
Gundersen, H.J. et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96, 379–394 (1988).
Lindbjerg Andersen, C., Ostergaard, M., Nielsen, B., Pedersen, B. & Koch, J. Characterization of three hairy cell leukemia–derived cell lines (ESKOL, JOK-1, and hair-M) by multiplex-FISH, comparative genomic hybridization, FISH, PRINS, and dideoxyPRINS. Cytogenet. Cell Genet. 90, 30–39 (2000).